Home - Products - Angiogenesis - PKC - 20-HETE

20-HETE

CAS No. 79551-86-3

20-HETE( —— )

Catalog No. M33247 CAS No. 79551-86-3

20-HETE promotes cell proliferation and migration in cancer and can be used to study prostate tumors and cardiac hypertrophy by activating the protein kinase C pathway to increase FBXO10 expression.

Purity : >98% (HPLC)

COA

Datasheet

HNMR

HPLC

MSDS

Handing Instructions

Size	Price / USD	Stock	Quantity
5MG	7211	In Stock
100MG	Get Quote	In Stock
200MG	Get Quote	In Stock
500MG	Get Quote	In Stock
1G	Get Quote	In Stock

Get Quotation Bulk Inquiry Add to Cart

Biological Information

Product Name

20-HETE
Note

Research use only, not for human use.
Brief Description

20-HETE promotes cell proliferation and migration in cancer and can be used to study prostate tumors and cardiac hypertrophy by activating the protein kinase C pathway to increase FBXO10 expression.
Description

20-HETE promotes cell proliferation and migration in cancer and can be used to study prostate tumors and cardiac hypertrophy by activating the protein kinase C pathway to increase FBXO10 expression.20-HETE promotes cell proliferation and migration in cancer and can be used to study prostate tumors and cardiac hypertrophy by activating the protein kinase C pathway.
In Vitro

——
In Vivo

——
Synonyms

——
Pathway

Angiogenesis
Target

PKC
Recptor

PKC
Research Area

——
Indication

——

Chemical Information

CAS Number

79551-86-3
Formula Weight

320.47
Molecular Formula

C20H32O3
Purity

>98% (HPLC)
Solubility

——
SMILES

C(=C\C/C=C\C/C=C\CCCCCO)\C/C=C\CCCC(O)=O
Chemical Name

——

Shipping & Storage Information

Storage

(-20℃)
Shipping

With Ice Pack
Stability

≥ 2 years

Reference

Calculator

Molecular Weight Calculator

Dilution Calculator

Molarity Calculator

molnova catalog

related products

Pim-1 kinase inhibit...

Pim-1 kinase inhibitor 8 is a potent Pim-1 kinase inhibitor with anticancer activity and can effectively inhibit cell migration.
CGP60474

A potent CDK1 inhibitor with IC50 of 17 nM; exhibits lower potency at CDK2 and moderate potency at CDK4.
Go 6983

Go 6983 is a pan-PKC inhibitor against for PKCα, PKCβ, PKCγ and PKCδ with IC50 of 7 nM, 7 nM, 6 nM and 10 nM, respectively.

Sign In Join Free